Home
Live Updates
BiVictriX Therapeutics PLC identifies a development lead for its BVX001 cancer programme : comparemela.com
BiVictriX Therapeutics PLC identifies a development lead for its BVX001 cancer programme
BiVictriX Therapeutics PLC (AIM:BVX, OTC:BVTXF), an emerging biotechnology company applying a novel approach to develop next-generation cancer therapies...
Related Keywords
,
Bivictrix Therapeutics ,
Antibody Drug Conjugates ,
Acute Myeloid Leukaemia ,
Tiffany Thorn ,
comparemela.com © 2020. All Rights Reserved.